2dd862931b08fa4f…

{
  "id": "NCT00112073",
  "type": "Study",
  "data": {
    "briefSummary": "The purpose of this study is to assess the safety and tolerability of multiple doses of AAB-001 passive immunization in patients with mild to moderate Alzheimer's disease (AD).",
    "completionDate": "2008-12",
    "conditions": [
      "Alzheimer's Disease"
    ],
    "enrollmentCount": 234,
    "enrollmentType": "ACTUAL",
    "nctId": "NCT00112073",
    "phase": "PHASE2",
    "sponsorId": "janssen-alzheimer-immunotherapy-research-development-llc",
    "startDate": "2005-04",
    "status": "COMPLETED",
    "studyType": "INTERVENTIONAL",
    "title": "A Phase IIA, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, and Immunogenicity Trial of AAB-001 in Patients With Mild to Moderate AD",
    "url": "https://clinicaltrials.gov/study/NCT00112073"
  }
}